← Leaderboards
Parag Goyal
Weill Medical Coll Of Cornell Univ
$4,164,920
Attributed
$5,406,956
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,406,956 · 6
By mechanism
R01$3,511,179 · 3
K76$1,144,559 · 1
R21$485,773 · 1
R03$265,445 · 1
Top collaborators
- Megan Johnson Shen2 shared
- Andrew Reis Zullo2 shared
- Andrew Patrick Ambrosy1 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Jiang Bian$15,427,176
- Andrew M Ryan$9,748,225
- Jason Mathew Butler$8,950,258
Others in their field
Other Emerging Leaders on “Elderly”
- Ted Ross · University Of Georgia$71,962,304
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Olwen Hahn · Brigham And Women'S Hospital$30,838,934
- Jennifer Marie Suga · Kaiser Foundation Research Institute$25,722,415
- Badri N Vardarajan · University Of Miami School Of Medicine$24,132,011
Research focus
ElderlyAgingImpairmentHeart FailureFutureInnovationParticipantPharmaceutical PreparationsCardiologyPolypharmacyClinical TrialsEfracMortalityAffectPatient Outcomes AssessmentsCaringFundingPatient OrientedGeriatricsBiometryMultiple Chronic ConditionsAreaHospitalizationEvent
Grant awards (14)
Preventing Myocardial Events of Aging: A PREVENTABLE Ancillary Study$702,180
R01 · FY2025 · AG · contact PI
DEPRESCRIBE-HFPEF$698,754
R01 · FY2025 · AG · contact PI
Post-Acute Care Medication Use and Functional Recovery in Heart Failure$622,634
R01 · FY2025 · AG
Preventing Myocardial Events of Aging: A PREVENTABLE Ancillary Study$810,699
R01 · FY2024 · AG · contact PI
Post-Acute Care Medication Use and Functional Recovery in Heart Failure$676,912
R01 · FY2024 · AG
Advancing the Conversations Helpful for Awareness of Illness Trajectory (CHAT) Intervention$255,403
R21 · FY2024 · AG · contact PI
A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and Polypharmacy$212,756
K76 · FY2024 · AG · contact PI
Advancing the Conversations Helpful for Awareness of Illness Trajectory (CHAT) Intervention$230,370
R21 · FY2023 · AG · contact PI
A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and Polypharmacy$222,702
K76 · FY2023 · AG · contact PI
A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and Polypharmacy$229,668
K76 · FY2022 · AG · contact PI
A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and Polypharmacy$236,433
K76 · FY2021 · AG · contact PI
A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and Polypharmacy$243,000
K76 · FY2020 · AG · contact PI
Impact of Polypharmacy on Rehospitalization in Older Adults with Heart Failure$125,040
R03 · FY2018 · AG · contact PI
Impact of Polypharmacy on Rehospitalization in Older Adults with Heart Failure$140,405
R03 · FY2017 · AG · contact PI